ELIFE 润色咨询

eLife

出版年份：暂无数据 年文章数：12320 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：4.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2019-07-17 ms7296194897309127

    很难，需要一定的创新性和新颖性，比较重要的意义。
    我的因意义较小被拒。
    期刊官方网站：https://elifesciences.org/
    期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2019-05-09 qq8680

    一审大概多久返回审稿意见？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-08-08 ms622773450447966

    很难发

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-08-08 ms3309476956082021

    审稿速度:6.0 | 投稿命中率:75.0
    经验分享：很难发

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-05-14 fzyi11

    谁有投稿的status啊，给分享一个呗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-05-09 fnianwan

    审稿速度:3.0 | 投稿命中率:5.0
    经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-02-12 Dr. H

    一审速度怎么样?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 哈哈张

    感觉elife在国内关注度不高呀.

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 哈哈张

    投NS能被送审就还不错了Ronaldo Alien 2018-01-09 发表::
    研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.    Ronaldo Alien 2018-01-09 23:49:00 发表:
    最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.

    Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=852645, encodeId=c4568526457c, content=很难，需要一定的创新性和新颖性，比较重要的意义。<br> 我的因意义较小被拒。<br> 期刊官方网站：https://elifesciences.org/<br> 期刊投稿网址：https://submit.elifesciences.org/cgi-bin/main.plex , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05265414134, createdName=ms7296194897309127, createdTime=Wed Jul 17 09:43:07 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570637, encodeId=9ab25e063739, content=一审大概多久返回审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0e4805220, createdName=qq8680, createdTime=Thu May 09 09:11:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846016, encodeId=79178460161a, content=很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Wed Aug 08 14:43:12 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846015, encodeId=4fb08460152b, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享：很难发 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Aug 08 14:43:09 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556041, encodeId=49a555604127, content=谁有投稿的status啊，给分享一个呗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6841627738, createdName=fzyi11, createdTime=Mon May 14 09:02:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555899, encodeId=bccc555899dd, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：很难投，投了大半年，经过3次修改，才录用，对创新性、研究方法、数据统计方法，要求都很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be862932, createdName=fnianwan, createdTime=Wed May 09 18:16:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552631, encodeId=8f1055263102, content=一审速度怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551226, encodeId=5aa7551226d0, content=感觉elife在国内关注度不高呀., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551227, encodeId=a67455122efb, content=投NS能被送审就还不错了<span class="quote">Ronaldo Alien 2018-01-09 发表::<br>研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span><span class="quote">Ronaldo Alien 2018-01-09 23:49:00 发表:<br>最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest.</span>, beContent=Ronaldo Alien 2018-01-09 发表:: 研究方向:cancer biology;; 接收率:约25% 审稿时间:约2个月 最近刚中了一篇.该文之前曾在Science和Nature 都送审过.审稿人多数认为缺乏创新.转投NC也被拒.不得已投elife.一个月审稿.半个月讨论.最终给了很高评价.极具创新性.仅用一天就修回并被接受.同时被推荐配发elife digest., objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551228, encodeId=e02c55122836, content=不知道elife18年能不能过7分呀<span class="quote">CR10 2017-12-28 发表::<br>Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 </span><span class="quote">CR10 2017-12-28 20:48:00 发表:<br>Nature Communications: 73591/(6721+15) = 10.925 <br> Science Advances: 6814/(726+15) = 9.195 <br> Developmental Cell: 3635/(372+38) = 8.865 <br> PNAS: 55771/6468 = 8.622 <br> Cell Reports: 13710/1866 = 7.347 <br> eLife: 13222/1979 = 6.681 <br> <br> <br> </span>, beContent=CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/05/f2c09f13d3cdbae7b2aaa9f03824ffb0.jpg, createdBy=3a411998349, createdName=哈哈张, createdTime=Fri Jan 12 00:00:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 哈哈张

    不知道elife18年能不能过7分呀CR10 2017-12-28 发表::
    Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681     CR10 2017-12-28 20:48:00 发表:
    Nature Communications: 73591/(6721+15) = 10.925
    Science Advances: 6814/(726+15) = 9.195
    Developmental Cell: 3635/(372+38) = 8.865
    PNAS: 55771/6468 = 8.622
    Cell Reports: 13710/1866 = 7.347
    eLife: 13222/1979 = 6.681


    CR10 2017-12-28 发表:: Nature Communications: 73591/(6721+15) = 10.925 Science Advances: 6814/(726+15) = 9.195 Developmental Cell: 3635/(372+38) = 8.865 PNAS: 55771/6468 = 8.622 Cell Reports: 13710/1866 = 7.347 eLife: 13222/1979 = 6.681

    0

共222条页码: 7/23页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分